Live feed16:00:00·7dNEWSReleasevia QuantisnowModerna Announces FDA Advisory Committee Votes Unanimously in Favor of the Benefit-Risk Profile of mRNA-1010, an Investigational Seasonal Influenza VaccineByQuantisnow·Wall Street's wire, on your screen.MRNA· Moderna Inc.Health Care
